Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

TNOX

Tanox (TNOX)

Tanox (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TNOX
DataHoraFonteTítuloCódigoCompanhia
02/08/200718:30PR Newswire (US)HealthShares(TM) Announces Change to the HealthShares(TM) Respiratory/Pulmonary IndexNASDAQ:TNOXTanox (MM)
09/05/200718:02PR Newswire (US)Tanox Reports 2007 First Quarter ResultsNASDAQ:TNOXTanox (MM)
15/03/200718:53PR Newswire (US)Tanox Reports Fourth Quarter and Full Year 2006 ResultsNASDAQ:TNOXTanox (MM)
29/01/200711:36PR Newswire (US)Genentech and Tanox Receive 'Second Request' from the Federal Trade CommissionNASDAQ:TNOXTanox (MM)
15/01/200717:43PR Newswire (US)Tanox, Inc. Stockholders Approve Merger With Genentech, Inc.NASDAQ:TNOXTanox (MM)
09/11/200620:50PR Newswire (US)Genentech Announces Agreement to Acquire Tanox for $20 Per ShareNASDAQ:TNOXTanox (MM)
02/11/200608:30PR Newswire (US)Tanox Reports 2006 Third Quarter ResultsNASDAQ:TNOXTanox (MM)
25/10/200608:00PR Newswire (US)Tanox Initiates Phase 1 Clinical Trial Evaluating TNX-650 for Treatment of AsthmaNASDAQ:TNOXTanox (MM)
24/10/200619:10PR Newswire (US)Tanox to Report Third Quarter 2006 Financial Results, Host Conference Call for Investors Nov. 2NASDAQ:TNOXTanox (MM)
14/09/200616:03PR Newswire (US)Tanox to Present at UBS Global Life Sciences ConferenceNASDAQ:TNOXTanox (MM)
31/08/200609:00PR Newswire (US)Tanox to Present at the Bear Stearns Healthcare ConferenceNASDAQ:TNOXTanox (MM)
17/08/200615:00PR Newswire (US)New Data Confirm Durable Response of TNX-355 Regimens Through 48 Weeks in Treatment-Experienced HIV PatientsNASDAQ:TNOXTanox (MM)
08/08/200607:30PR Newswire (US)Tanox Reports 2006 Second Quarter ResultsNASDAQ:TNOXTanox (MM)
03/08/200619:45PR Newswire (US)Tanox Conducts Meeting With Food and Drug Administration Regarding Its HIV/AIDS Antibody, TNX-355NASDAQ:TNOXTanox (MM)
18/07/200610:00PR Newswire (US)Tanox to Report Second Quarter 2006 Financial Results, Host Conference Call for Investors Aug. 8NASDAQ:TNOXTanox (MM)
31/05/200620:21PR Newswire (US)Results of TNX-355 Combination Study Published in Antimicrobial Agents and ChemotherapyNASDAQ:TNOXTanox (MM)
23/05/200607:00PR Newswire (US)First Patient Dosed in Phase 1 Trial of Tanox's TNX-650NASDAQ:TNOXTanox (MM)
02/05/200607:00PR Newswire (US)Tanox Reports 2006 First Quarter ResultsNASDAQ:TNOXTanox (MM)
02/05/200606:00PR Newswire (US)Tanox Reports 48-Week Results From TNX-355 Phase 2 Clinical TrialNASDAQ:TNOXTanox (MM)
17/04/200617:30PR Newswire (US)Tanox to Present at Two Investor Conferences in MayNASDAQ:TNOXTanox (MM)
10/04/200614:00PR Newswire (US)Tanox to Report First Quarter 2006 Financial Results, Host Conference Call for Investors May 2NASDAQ:TNOXTanox (MM)
28/02/200608:30PR Newswire (US)Tanox Reports Fourth Quarter and Full Year 2005 ResultsNASDAQ:TNOXTanox (MM)
09/02/200617:00PR Newswire (US)New Research Reaffirms Tropism Independence of TNX-355; Data for Tanox's Novel HIV Viral Entry Inhibitor Presented at 2006 CROINASDAQ:TNOXTanox (MM)
09/02/200601:30PR Newswire (US)Tanox to Report 2005 Fourth Quarter and Full Year Results Feb. 28NASDAQ:TNOXTanox (MM)
03/02/200613:34PR Newswire (US)Tanox to Present at Two Investor Conferences in FebruaryNASDAQ:TNOXTanox (MM)
23/01/200610:00PR Newswire (US)Tanox Receives Multimillion Xolair(R) Milestone PaymentNASDAQ:TNOXTanox (MM)
04/01/200616:29PR Newswire (US)Tanox to Present at JP Morgan Healthcare ConferenceNASDAQ:TNOXTanox (MM)
20/12/200517:14PR Newswire (US)Tanox Submits Investigational New Drug Application for TNX-650 for Treatment of Hodgkin's LymphomaNASDAQ:TNOXTanox (MM)
17/12/200516:30PR Newswire (US)Data Indicates Tanox HIV Drug Candidate Active In Vitro Against CCR5 and CXCR4 Viruses and Synergistic with Entry InhibitorNASDAQ:TNOXTanox (MM)
17/12/200513:30PR Newswire (US)Additional Phase 2 Data Supports Further Development of Tanox's Novel HIV TherapyNASDAQ:TNOXTanox (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:TNOX